The Involvement of AMPA Receptor in the Antidepressant-like Effects of the Portulaca Oleracea L. Extract in Mice

키워드

참고문헌 (48)

1. WHO, "WHO World Health Statistics, In Statistical Highlights in Global Public Health" (2010)
2. Committee of Neuropsychiatrical Textbook in National Korean Medicine, "Psychiatry of Korean Medicine", pp.256~502 (2007), Jibmundang
3. Duman RS, "A Molecular and Cellular Theory of Depression", Arch Gen Psychiatry, 54(7), pp.597~606 (1997)
4. Kim YG, "Neurobiology of Depression", Korean Medical Association Paper, 9, pp.783~789 (2003)
5. Butler SG, "Recent Developments in the Design of Anti-depressive Therapies;targeting the Serotonin Transporter", Curr Med Chem, 15(17), pp.1737~1761 (2008)
6. Steru L, "The Tail Suspension Test: A New Method for Screening Antidepressants in Mice", Psychopharmacology, 85(3), pp.367~370 (1985)
7. Bymaster FP, "New Approachest Developing Antidepressants by Enhancing Monoaminergic Neurotransmission", Expert Opin Investig Drugs, 12(4), pp.531~543 (2003)
8. Segrave R, "Pindolol Augmentation of Selective Serotonin Reuptake Inhibitors: Accounting for the Variability of Results of Placebo-controlled Double-blind Studies in Patients with Major Depression", Hum Psychopharmacol, 20(3), pp.163~174 (2005)
9. Cowen PJ, "A Role for 5-HT in the Action of Antidepressant Drugs", Pharmacol Ther, 46(1), pp.43~51 (1990)
10. Anttila SA, "A Review of the Pharmacological and Clinical Profile of Mirtazapine", CNS Drug Rev, 7(3), pp.249~264 (2001)
11. Masand PS, "Long-term Side Effects of Newer-generation Antidepressants: S SRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine", Ann Clin Psychiatry, 14(3), pp.175~182 (2002)
12. Fava M, "Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: a Literature Review and a Proposal for a Novel Approach to Improve Practice", Psychother Psychosom, 75(3), pp.139~153 (2006)
13. "Pharmacology Session in the Council of Korean Pharmaceutical College: Pharmacology", pp.212~227 (2005), Sin-il Inc
14. Newman DJ, "Natural Products as Sources of New Drugs Over the Period 1981-2002", J Nat Prod, 66(7), pp.1022~1037 (2003)
15. Zhang ZJ, "Therapeutic Effects of Herbal Extracts and Constituents in Animal Models of Psychiatric Disorders", Life Sci, 75(14), pp.1659~1699 (2004)
16. Chang-Hwan Lee, "Anxiolytic-like effects of Portulaca oleraceae L. using the elevated plus-maze in mice", Oriental Pharmacy and Experimental Medicine, 9(2), pp.135~141 (2009), 한의학연구소
17. Sakai N, "Portuloside A, a Monoterpene Glucoside, from Portulaca Oleracea", Phytochemistry, 42, pp.1625~1628 (1996)
18. Zhou J, "Isolation and Assaying of Polysaccharides in Portulaca Oleracea", Chin Tradit Herb Drug, 32, pp.124~125 (2001)
19. Yue M-E, "Simultaneous Determination of Noradrenaline and Dopamine in Portulaca Oleracea L. by Capillary Zone Electrophoresis", Journal of Separation Science, 28, pp.360~364 (2005)
20. Porsolt RD, "Behavioral Despair in Mice: a Primary Screening Test for Antidepressants", Arch Int Pharmacodyn Ther, 229(2), pp.327~336 (1977)
21. Le Pichon M, "Depression: a New Animal Model Sensitive to Antidepressant Treatments", Nature, 266(5604), pp.730~732 (1977)
22. Jick H, "Antidepressants and the Risk of Suicidal Behaviors", JAMA, 292(3), pp.338~343 (2004)
23. Mineur YS, "Antidepressant- like Effects of Ceftriaxone in Male C57BL", 6J Mice, 2007, pp.61(2), 250~252
24. Paul IA, "Glutamate and Depression: Clinical and Preclinical Studies", Ann N Y Acad Sci, 1003, pp.250~272 (2003)
25. Sanacora G, "Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders", Ann N Y Acad Sci, 1003, pp.292~308 (2003)
26. Bleakman D, "AMPA Receptors in the Therapeutic Management of Depression", CNS Neurol Disord Drug Targets, 6(2), pp.117~126 (2007)
27. Alt A, "AMPA Receptor Potentiators as Novel Antidepressants", Curr Pharm Des, 11(12), pp.1511~1527 (2005)
28. Maeng S, "Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of Alpha-amino-3-hydroxy-5-methylisoxazole- 4-propionic acid Receptors", Biol Psychiatry, 63(4), pp.349~352 (2008)
29. Skolnick P, "AMPA Receptors: a Target for Novel Antidepressants", Biol Psychiatry, 63(4), pp.347~348 (2008)
30. Koike H, "Involvement of AMPA Receptor in both the Rapid and Sustained Antidepressant-like Effects of Ketamine in Animal Models of Depression", Behav Brain Res, 224(1), pp.107~111 (2011)
31. Chapman AG, "The Anticonvulsant Effect of the non-NMDA Antagonists, NBQX and GYKI 52466, in mice", Epilepsy Res, 9(2), pp.92~96 (1991)
32. Zheng ZH, "Modern Study of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine", pp.753~ (1997), Xue Yuan Press
33. Liu LX, "Fatty Acids and-carotene in Australian Purslane (Portulaca Oleracea) Varieties", Journal of Chromatography A, 893, pp.207~213 (2000)
34. Awad NE, "Lipid Content and Antimicrobial Activity of Phenolic Constituents of Cultivated Portulaca Oleracea L", Bulletin of Faculty of Pharmacy of CairoUniversity, 32, pp.137~142 (1994)
35. Boyce P, "The Place for the Tricyclic Antidepressants in the Treatment of Depression", AustN Z J Psychiatry, 33(3), pp.323~327 (1999)
36. Zhu L, "Up-regulation of HIF-1alpha Expression Induced by Ginkgolides in Hypoxic Neurons", Brain Research, 1166, pp.1~8 (2007)
37. Chen CJ, "Anti-hypoxic Activity of the Ethanol Extract from Portulaca Oleracea in Mice", Journal of Ethnopharmacology, 124, pp.246~250 (2009)
38. Radhakrishnan R, "Neuropharmacological Actions of Portulaca Oleraceae Lv. sativa (Hawk)", J Ethnopharmacol, 76, pp.171~176 (2001)
39. Pellow S, "Validation of Open-closed Arm Entries in an Elevated Plus-maze as a Measure of Anxiety in the Rat", J Neurosci Methods, 14, pp.149~167 (1985)
40. Bonetti EP, "Benzodiazepine Antagonist R15-1788: Neurological and Behavioral Effects", Psychopharmacology, 78, pp.8~18 (1982)
41. Overstreet DH, "Administration of Antidepressants, Diazepam and Psychomotor Stimulants Further Confirms the Utility of Flinders Sensitive Line Rats as an Animal Model of Depression", Psychopharmacology, 121(1), pp.27~37 (1995)
42. Sanacora G, "Towards a Glutamate Hypothsis of Depression. An Emerging Frontier of Neuropsychopharmacology for Mood Disorders", Neuropharmacology, 62, pp.63~77 (2012)
43. Li X, "Antidepressant-like Actions of an AMPA Receptor Potentiator (LY392098)", Neuropharmacology, 40(8), pp.1028~1033 (2001)
44. Alt A, "A Role for AMPA Receptors in Mood Disorders", Biochem Pharmacol, 71(9), pp.1273~1288 (2006)
45. Du J, "The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders", Neuropsychopharmacology, 32(4), pp.793~802 (2007)
46. Li X, "Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors", Cell Mol Neurobiol, 23(3), pp.419~430 (2003)
47. Martinez-Turrillas R, "Chronic Antidepressant Treatment Increases the Membrane Expression of AMPA Receptors in Rat Hippocampus", Neuropharmacology, 43(8), pp.1230~1237 (2002)
48. Svenningsson P, "Involvement of Striatal and Extrastriatal DARPP-32 in Biochemical and Behavioral Effects of Fluoxetine (Prozac)", Proc Natl Acad Sci U S A, 99(5), pp.3182~3187 (2002)

관련 논문AI추천